- Home
- SATL vs ANEB Comparison
SATL vs ANEB Comparison
Compare SATL & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SATL
- ANEB
- Stock Information
- Founded
- SATL 2010
- ANEB 2020
- Country
- SATL Uruguay
- ANEB United States
- Employees
- SATL N/A
- ANEB N/A
- Industry
- SATL Radio And Television Broadcasting And Communications Equipment
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- SATL Technology
- ANEB Health Care
- Exchange
- SATL Nasdaq
- ANEB Nasdaq
- Market Cap
- SATL 91.1M
- ANEB 79.9M
- IPO Year
- SATL N/A
- ANEB 2021
- Fundamental
- Price
- SATL $1.01
- ANEB $1.84
- Analyst Decision
- SATL
- ANEB Buy
- Analyst Count
- SATL 0
- ANEB 1
- Target Price
- SATL N/A
- ANEB $8.00
- AVG Volume (30 Days)
- SATL 45.4K
- ANEB 6.6K
- Earning Date
- SATL 10-29-2024
- ANEB 11-12-2024
- Dividend Yield
- SATL N/A
- ANEB N/A
- EPS Growth
- SATL N/A
- ANEB N/A
- EPS
- SATL N/A
- ANEB N/A
- Revenue
- SATL $13,719,000.00
- ANEB N/A
- Revenue This Year
- SATL N/A
- ANEB N/A
- Revenue Next Year
- SATL N/A
- ANEB N/A
- P/E Ratio
- SATL N/A
- ANEB N/A
- Revenue Growth
- SATL 101.51
- ANEB N/A
- 52 Week Low
- SATL $0.69
- ANEB $1.72
- 52 Week High
- SATL $2.52
- ANEB $3.30
- Technical
- Relative Strength Index (RSI)
- SATL 50.18
- ANEB 45.94
- Support Level
- SATL $0.97
- ANEB $1.83
- Resistance Level
- SATL $1.02
- ANEB $1.96
- Average True Range (ATR)
- SATL 0.04
- ANEB 0.08
- MACD
- SATL 0.00
- ANEB -0.00
- Stochastic Oscillator
- SATL 52.94
- ANEB 10.25
About SATL Satellogic Inc.
Satellogic Inc is a provider of satellite imagery to governments and commercial customers globally. It geographically operates in North America, Europe, Asia and South America. It derives maximum revenue from Asia Pacific.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.